C.J. Gelatine Products Ltd.

C.J. Gelatine Products Ltd.

BBSE:CJGEL
23.93
INR
-2.51
(-9.49%)
0.96EPS
22.86P/E
105.89MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
31.02
36.9
46.85
34.37
47.81
53.62
58.76
81.1
82.14
76.46
84.96
85.78
87.47
91.99
Basic EPS, GAAP
-0.42
0.13
0.27
-4.17
0.13
0.78
0.46
0.72
0.72
0.48
-4.05
0.17
0.43
0.96
Free Cash Flow per Basic Share
1.84
1.42
-0.04
0.9
3.8
2.05
-13.53
-9.16
-11
-0.31
2.64
-0.27
-2.72
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
27.26
26.08
25.17
19.82
18.77
18.38
17.66
16.18
15.72
15.03
9.83
8.7
8.11
- -
Tangible Book Value per Share
27.26
26.08
25.17
19.82
18.77
18.38
17.66
16.18
15.72
15.03
9.83
8.7
8.11
- -
Basic Weighted Avg Shares
5
5
5
5
5
5
5
5
5
5
5
5
5
5
Sales/Revenue/Turnover
149
178
226
165
230
258
283
390
395
368
409
413
421
443
Operating Margin (%)
0.44
5.95
6.46
-2.52
3.85
5.91
4.62
3.69
4.07
2.98
3.33
2.69
3.98
4.68
Depreciation Expense
2
3
3
3
4
4
4
10
5
11
11
11
12
6
Net Income, GAAP
-2
1
1
-20
1
4
2
3
3
2
-19
1
2
5
Effective Tax Rate (%)
- -
19.06
30.91
- -
19.05
26.1
9.46
12.01
14.85
28.02
- -
58.28
29.23
19.13
Profit Margin (%)
-1.36
0.36
0.57
-12.14
0.27
1.45
0.78
0.89
0.88
0.62
-4.76
0.19
0.5
1.05
Working Capital
43
48
73
63
41
39
53
67
89
91
80
102
117
- -
LT Debt
16
18
47
60
37
31
43
60
94
100
94
116
135
- -
Total Equity
131
126
121
95
90
88
85
78
76
72
47
42
39
- -
Return on Invested Capital (%)
- -
0.43
0.79
- -
5.14
7.03
7.29
6.46
5.76
2.97
- -
1.88
4.5
- -
Return on Capital (%)
- -
5.19
6.37
- -
5.28
7.13
6.98
6.52
5.84
4.47
- -
2.43
4.48
- -
Return on Common Equity (%)
-1.5
0.49
1.04
-18.55
0.66
4.17
2.53
4.26
4.52
3.1
-32.56
1.79
5.15
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
102
- -
LT Borrowings
- -
135
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
79
83
106

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
269
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
39
- -
Inventories
- -
227
- -
Total Current Liabilities
- -
152
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
102
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-10.11%
-12.02%
-6.82%
Free Cash Flow
-315.11%
-45.24%
913.06%
Net Income, GAAP
-217.97%
-185.22%
160.95%
Sales/Revenue/Turnover
8.06%
1.69%
1.97%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
89
101
109
114
413
2026
84
121
102
114
421
2027
106
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.1
-0.5
0.36
0.1
0.17
2026
-0.29
0.08
0.23
0.36
0.43
2027
0.29
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Jaspal Singh
Full Time Employees
60
Sector
Consumer non-durables
Industry
Food: specialty/candy
Address
B-Shop-05, Plot No. 237 Mumbai MA India 400015
IPO Date
Jul 13, 1993
Business
C.J. Gelatine Products Limited C.J. Gelatine Products Limited engages in the manufacture and sale of gelatine and related by-products in India. The company produces pharmaceutical gelatine, edible gelatine, technical gelatine, photographic gelatine, ossein, and di-calcium phosphate (DCP), serving industries including pharmaceuticals, food and confectionery, technical applications, photography, and animal feed; its manufacturing facility is located at 21, New Industrial Area, Mandideep, District Raisen, Bhopal, Madhya Pradesh. Founded on September 25, 1980, and headquartered in Mumbai, Maharashtra, the company operates primarily within India with a focus on domestic markets. Recent developments include the appointment of secretarial auditors for FY 2025-2026 to FY 2029-2030, amendments to the Memorandum of Association approved at the 45th AGM on September 27, 2025, reappointments of executive directors and statutory auditors at the 44th AGM in September 2024, and routine board approvals for internal auditors and financial results disclosures in 2025.